Esperion Therapeutics Inc... (ESPR)
2.13
-0.11 (-4.91%)
At close: Jan 15, 2025, 12:50 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY02 | FY01 | FY00 | FY99 |
| Net Income | -209.25M | -233.66M | -269.11M | -143.55M | -97.17M | -201.81M | -166.99M | -74.98M | -49.78M | -36.38M | -26.09M | -11.74M | -10.82M | -28.73M | -24.93M | -27.58M | -10.67M |
| Depreciation & Amortization | 164.00K | 500.00K | 612.00K | 547.00K | 319.00K | 265.00K | 258.00K | 252.00K | 236.00K | 160.00K | 70.55K | 139.43K | 178.47K | -1.29M | -2.01M | -2.05M | -683.22K |
| Stock-Based Compensation | 11.96M | 15.21M | 24.31M | 28.39M | 25.88M | 23.97M | 18.61M | 15.96M | 12.73M | 3.68M | 1.23M | 79.86K | 78.45K | n/a | n/a | n/a | n/a |
| Other Working Capital | 50.18M | 2.63M | 10.39M | -490.00K | 8.76M | 4.71M | 708.00K | 6.09M | -756.00K | 550.00K | 1.47M | -625.27K | 182.68K | 777.00K | -249.00K | 356.00K | 3.14M |
| Other Non-Cash Items | 47.96M | 46.49M | 35.53M | 33.80M | 8.12M | -217.00K | 23.00K | 44.00K | 61.00K | 31.00K | 936.58K | 1.50M | 581.47K | 3.92M | 5.24M | 8.70M | 1.64M |
| Deferred Income Tax | n/a | n/a | -2.63M | -97.00K | -200.00K | n/a | 334.00K | 1.01M | 694.00K | 233.00K | 2.51M | 51.97K | 108.31K | n/a | n/a | n/a | n/a |
| Change in Working Capital | 13.68M | -3.37M | -52.51M | -4.26M | -7.30M | 29.16M | 16.47M | 9.98M | -2.09M | 251.00K | 3.23M | -840.17K | 801.92K | -465.00K | -1.06M | 2.98M | 1.86M |
| Operating Cash Flow | -135.49M | -174.83M | -263.81M | -85.18M | -70.34M | -148.64M | -131.30M | -47.73M | -38.16M | -32.02M | -18.11M | -10.81M | -9.07M | -26.56M | -22.77M | -17.95M | -7.85M |
| Capital Expenditures | n/a | n/a | n/a | -13.37M | -953.00K | -151.00K | -19.00K | -94.00K | -325.00K | -873.00K | -31.37K | -6.78K | -33.63K | -1.16M | -2.02M | -1.34M | -1.56M |
| Acquisitions | n/a | n/a | n/a | 12.50M | -65.18M | n/a | n/a | n/a | 24.00K | n/a | n/a | n/a | n/a | n/a | n/a | -233.00K | n/a |
| Purchase of Investments | n/a | -59.90M | -50.48M | -4.42M | -34.33M | -25.48M | -219.58M | -197.23M | -280.56M | -48.09M | -24.68M | n/a | n/a | -37.22M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 42.50M | 68.00M | n/a | 39.15M | 99.51M | 166.08M | 183.74M | 207.44M | 120.79M | 12.35M | 3.50M | n/a | 500.35K | 32.86M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 8.10M | -50.48M | -12.50M | 65.18M | 140.60M | -35.83M | 10.21M | 24.00K | 12.00K | 201.26K | 5.10K | 42.31K | 30.00K | -105.00K | -450.00K | n/a |
| Investing Cash Flow | 42.50M | 8.10M | -50.48M | 21.36M | 64.23M | 140.45M | -35.85M | 10.12M | -160.07M | -36.60M | -21.00M | -1.68K | 509.03K | -5.48M | -2.13M | -2.02M | -1.56M |
| Debt Repayment | n/a | n/a | n/a | 271.60M | n/a | -1.05M | -1.71M | -1.60M | -638.00K | 4.84M | n/a | 15.41M | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | -55.00M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -6.42M | -58.24M | 49.53M | -14.87M | 136.19M | 11.74M | 1.17M | 45.00K | 1.18M | 92.28M | 89.02M | 10.00 | 6.72M | 1.44M | 25.02M | 84.12M | 2.78M |
| Financial Cash Flow | 50.46M | 32.61M | 268.22M | 201.72M | 136.19M | 10.69M | 163.46M | -1.56M | 190.52M | 97.12M | 89.14M | 15.75M | 6.72M | 1.44M | 25.02M | 84.12M | 2.78M |
| Net Cash Flow | -42.53M | -134.12M | -46.07M | 137.90M | 130.09M | 2.50M | -3.70M | -39.17M | -7.70M | 28.50M | 50.03M | 4.94M | -1.84M | -29.79M | 58.00K | 64.32M | -6.64M |
| Free Cash Flow | -135.49M | -174.83M | -263.81M | -98.55M | -71.29M | -148.79M | -131.32M | -47.82M | -38.48M | -32.89M | -18.14M | -10.82M | -9.10M | -27.72M | -24.79M | -19.30M | -9.42M |